This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.2.0: STU 1 Ballot 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
<ValueSet xmlns="http://hl7.org/fhir"> <id value="valueset-methylprednisolone-exclude"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a> version <code>02-Jul-2018</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1100391</td><td>methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil]</td><td/></tr><tr><td>1100390</td><td>Methylprednisolone Topical Gel [HybriSil]</td><td/></tr><tr><td>1358506</td><td>methylprednisolone acetate 0.0025 MG/MG Topical Ointment</td><td/></tr><tr><td>1100387</td><td>methylprednisolone acetate 0.01 MG/MG Topical Gel</td><td/></tr><tr><td>1100386</td><td>Methylprednisolone Topical Gel</td><td/></tr><tr><td>372863</td><td>Methylprednisolone Topical Ointment</td><td/></tr><tr><td>1163491</td><td>Methylprednisolone Topical Product</td><td/></tr><tr><td>1172713</td><td>HybriSil Topical Product</td><td/></tr></table></li></ul></div> </text> <url value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-methylprednisolone-exclude"/> <version value="0.2.0"/> <name value="Valueset_methylprednisolone_exclude"/> <title value="Exclude Methylprednisolone Medications Value Set"/> <status value="draft"/> <date value="2018-07-02"/> <publisher value="PDDI CDS"/> <contact> <name value="Richard Boyce"/> </contact> <description value="ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <purpose value="To refine valueset for Warfarin + NSAID PDDI-CDS"/> <copyright value="Attribution CC BY"/> <compose> <include> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <version value="02-Jul-2018"/> <concept> <code value="1100391"/> <display value="methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil]"/> </concept> <concept> <code value="1100390"/> <display value="Methylprednisolone Topical Gel [HybriSil]"/> </concept> <concept> <code value="1358506"/> <display value="methylprednisolone acetate 0.0025 MG/MG Topical Ointment"/> </concept> <concept> <code value="1100387"/> <display value="methylprednisolone acetate 0.01 MG/MG Topical Gel"/> </concept> <concept> <code value="1100386"/> <display value="Methylprednisolone Topical Gel"/> </concept> <concept> <code value="372863"/> <display value="Methylprednisolone Topical Ointment"/> </concept> <concept> <code value="1163491"/> <display value="Methylprednisolone Topical Product"/> </concept> <concept> <code value="1172713"/> <display value="HybriSil Topical Product"/> </concept> </include> </compose> </ValueSet>